MiMedx Stock Hits New Low on Financial Restatements, CFO Switch

The biotech began an internal audit back in February

Jun 7, 2018 at 9:44 AM
facebook X logo linkedin


Shares of MiMedx Group Inc (NASDAQ:MDXG) have plunged 17.05% this morning to trade at $6.81 -- fresh off a four-year low of $5.80 -- on news the biopharmaceutical firm will restate financial statements from fiscal 2012 through 2016 and the first three quarters of 2017 in the wake of an internal audit that was sparked by a federal investigation. The Georgia-based company also named Edward Borkowski as chief financial officer (CFO), after Michael Senker stepped down from the position he was temporarily filling.

Since gapping into single digits after news of the probe first hit back in February, MDXG shares had been churning in the $6.50-to-$10.00 range. Not only does today's drop have the shares near levels not seen since mid-2014, but they are now staring at a nearly 50% year-to-date deficit.

Not surprisingly, there's plenty of skepticism priced into MDXG shares. Short interest edged up in the latest reporting period to 49.96 million shares. In addition to this being the most on record, these bearish bets represent a whopping 51% of the stock's available float. These traders are sidelined for the next two days, though, with MDXG landing on the short-sale restricted list this morning.

Options traders have been betting on bigger losses, too. Currently, 143,163 puts are open on MDXG, in the 96th percentile of its annual range. More than two-fifths of these contracts are centered at the June 5, 7.50, and 10 puts -- which make up three of MDXG's top four positions. Data from the major options exchanges and Trade-Alert point to buy-to-open activity at each strike, pointing to expectations for stiffer headwind through expiration at next Friday's close.

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI